Literature DB >> 29045025

Do preoperative oral antibiotics increase Clostridium difficile infection rates? An analysis of 13 959 colectomy patients.

M Parthasarathy1, D Bowers2, T Groot-Wassink1.   

Abstract

AIM: The aim of this study was to determine whether or not preoperative oral antibiotic preparation (POAP) increases the rate of Clostridium difficile colitis (CDC) in patients undergoing colectomy.
METHOD: In 2015, data for colectomies had been collected prospectively and recorded in the targeted colectomy option of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). This was available for retrospective analysis. Data available for analysis included elective and emergency status, POAP, surgical approach, primary anastomosis and CDC status. The effect of POAP on CDC was analysed and risk adjusted for 14 separate preoperative variables.
RESULTS: In all, 13 959 adult patients underwent a colectomy in 2015 (POAP group 5311 and non- POAP group 8648). The overall rate of CDC in colectomy patients was 1.6% (227/13 959). On univariate analysis, CDC was significantly less common in the POAP group than in the non-POAP group (1.2% vs 1.9%, P = 0.003). Univariate analysis of a further 41 preoperative variables revealed 14 to be associated with CDC. However, after risk adjustment with these 14 variables, POAP lost its statistical significance (adjusted OR 0.902, 95% CI 0.584-1.486, P = 0.685). Only patients with pre-existing systemic inflammatory response syndrome appeared to be at increased risk of CDC (adjusted OR 2.154, 95% CI 1.139-4.074, P = 0.018).
CONCLUSION: At the very least this study suggests it is safe to use POAP in colectomy patients without increasing the rate of CDC unless they have pre-existing systemic inflammatory response syndrome. Colorectal Disease
© 2017 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Clostridium difficile colitis; clinical database; colectomy; mechanical bowel preparation; oral antibiotics; postoperative complication

Mesh:

Substances:

Year:  2018        PMID: 29045025     DOI: 10.1111/codi.13926

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

1.  Preoperative oral antibiotic bowel preparation in elective resectional colorectal surgery reduces rates of surgical site infections: a single-centre experience with a cost-effectiveness analysis.

Authors:  B Vadhwana; A Pouzi; G Surjus Kaneta; V Reid; D Claxton; L Pyne; R Chalmers; A Malik; D Bowers; T Groot-Wassink
Journal:  Ann R Coll Surg Engl       Date:  2019-09-11       Impact factor: 1.891

2.  Effect of Inclusion of Oral Antibiotics with Mechanical Bowel Preparation on the Risk of Clostridium Difficile Infection After Colectomy.

Authors:  Ahmed M Al-Mazrou; Laura Z Hyde; Kunal Suradkar; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2018-07-02       Impact factor: 3.452

3.  The Role of Oral Antibiotic Preparation in Elective Colorectal Surgery: A Meta-analysis.

Authors:  Katie E Rollins; Hannah Javanmard-Emamghissi; Austin G Acheson; Dileep N Lobo
Journal:  Ann Surg       Date:  2019-07       Impact factor: 12.969

4.  Analysis of Perioperative Risk Factors for Clostridium difficile Infection After a Colectomy.

Authors:  Karen Kong; Sara S Soliman; Rolando H Rolandelli; Matthew J Elander; Joseph Flanagan; Daniel Hakakian; Zoltan H Nemeth
Journal:  Cureus       Date:  2021-12-03

5.  Selective decontamination of the digestive tract in colorectal surgery reduces anastomotic leakage and costs: a propensity score analysis.

Authors:  Andreas Bogner; Maximilian Stracke; Ulrich Bork; Steffen Wolk; Mathieu Pecqueux; Sandra Kaden; Marius Distler; Christoph Kahlert; Jürgen Weitz; Thilo Welsch; Johannes Fritzmann
Journal:  Langenbecks Arch Surg       Date:  2022-05-13       Impact factor: 2.895

6.  Mechanical plus oral bowel preparation with paromomycin and metronidazole reduces infectious complications in elective colorectal surgery: a matched case-control study.

Authors:  Matthias Mehdorn; Christoph Lübbert; Iris F Chaberny; Ines Gockel; Boris Jansen-Winkeln
Journal:  Int J Colorectal Dis       Date:  2021-04-25       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.